Liberty Health Sciences names Stephanie Kubacki as Vice President of Marketing
TORONTO, May 15, 2018 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) has named seasoned marketing executive Stephanie Kubacki as Vice President of Marketing, effective June 1, 2018. Ms. Kubacki comes to Liberty with and exceptional track record managing and building high-profile brands in the highly regulated beverage industry.
I am incredibly excited to welcome Stephanie to the leadership team where she will play an important role in pursuing our aggressive growth strategy. She has an impressive background and wealth of experience in developing and advancing some of the world’s most recognizable brands. She’s a tremendous talent and adds important depth to our team.
George Scorsis, Director and CEO of Liberty
With over 15 years experience in strategic and commercial brand marketing, Ms. Kubacki brings a wealth of leadership and industry knowledge to the Company. She started her career with Bacardi Canada Inc. where she oversaw the Bacardi Rums portfolio marketing group. She has extensive experience leading national, regional and multicultural marketing initiatives for Bacardi Canada, Diageo Spirits California and Palm Bay International. In addition to driving marketing on such brands as Bulleit Bourbon, Ciroc Vodka, Skinnygirl Margarita and Aperol, Ms. Kubacki has also led the strategic implementation of business-critical, big data, business intelligence systems for top-tier companies in the beverage alcohol industry.
I am thrilled to join one of the leading companies in the rapidly booming cannabis industry. I look forward to collaborating with such a strong team of innovators and game-changers as we work to convey the importance of education around the many benefits of Liberty’s medicinal cannabis products.
Stephanie Kubacki, Vice President of Marketing
For more information on Liberty, please visit www.libertyhealthsciences.com
About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.
For more information, please visit libertyhealthsciences.com
